All lobbying filings
CONTINENTAL STRATEGY, LLC
CONTINENTAL STRATEGY, LLC filed a Q3 termination report for DEXCOM on October 19, 2026, reporting no lobbying activity.
Lobbying for DEXCOM · Healthcare company that develops, manufactures, produces, and distributes CGMs.
Filing · LD-2 quarterly report
Q3 terminationNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$25,000
What the client paid this registrant for the period.
Client based in
California
Representation ended
Jul 31, 2026
The registrant reported terminating its work for this client.
Lobbying activity
0
No itemized activity in this filing.